Patents by Inventor Jean Shearin

Jean Shearin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to CD23, derivatives thereof, and their therapeutic uses
    Patent number: 7008623
    Abstract: The invention relates to antibodies which bind to the CD23 (FC?RII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FC?RII) type II molecule characterized by an affinity constant equal to or greater than 1×109 Ka Mol?1, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: March 7, 2006
    Assignee: Glaxo Wellcome Inc.
    Inventors: Jean-Yves Marcel Paul Bonnefoy, James Scott Crowe, Jonathan Henry Ellis, Nicholas Timothy Rapson, Jean Shearin
  • Method of predicting cell-based assay results using binding profiles
    Publication number: 20040002119
    Abstract: A rapid method of characterizing interactions between compounds and biological molecules in vitro, in order to predict the in vivo characteristics of the compounds, is described. Preferably, the methods utilize labeled microspheres in multiplexed assays.
    Type: Application
    Filed: April 11, 2003
    Publication date: January 1, 2004
    Inventors: Marie A. Iannone, Kenneth Hugh Pearce, Jean Shearin, Catherine Ann Simmons, Daniel Lee Svoboda, Dana Edward Vanderwall